CS
EW icon

Comerica Securities’s Edwards Lifesciences EW Stock Holding History

Comerica Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$338K Sell
4,878
-340
-7% -$27.3K 0.03% 335
2023
Q2 		$492K Sell
5,218
-670
-11% -$58.2K 0.03% 301
2023
Q1 		$487K Buy
5,888
+80
+1% +$6.29K 0.04% 300
2022
Q4 		$433K Buy
+5,808
New +$448K 0.03% 322
2022
Q1 		– Sell
-7,328
Closed -$949K – 499
2021
Q4 		$949K Buy
7,328
+293
+4% +$34.2K 0.06% 245
2021
Q3 		$796K Buy
+7,035
New +$803K 0.06% 269
2021
Q2 		– Sell
-5,752
Closed -$481K – 484
2021
Q1 		$481K Buy
5,752
+660
+13% +$55.8K 0.04% 325
2020
Q4 		$465K Buy
5,092
+1,516
+42% +$126K 0.04% 308
2020
Q3 		$285K Buy
3,576
+569
+19% +$44.4K 0.03% 351
2020
Q2 		$208K Buy
+3,007
New +$214K 0.02% 410
2019
Q4 		– Sell
-5,220
Closed -$383K – 447
2019
Q3 		$383K Sell
5,220
-8,139
-61% -$572K 0.04% 317
2019
Q2 		$823K Sell
13,359
-1,062
-7% -$64.2K 0.09% 212
2019
Q1 		$920K Buy
14,421
+72
+0.5% +$4.11K 0.1% 198
2018
Q4 		$733K Sell
14,349
-672
-4% -$34K 0.1% 204
2018
Q3 		$872K Sell
15,021
-3,711
-20% -$181K 0.1% 209
2018
Q2 		$909K Sell
18,732
-609
-3% -$28.4K 0.11% 207
2018
Q1 		$899K Sell
19,341
-120
-0.6% -$5.21K 0.11% 206
2017
Q4 		$731K Buy
19,461
+6,303
+48% +$231K 0.09% 228
2017
Q3 		$479K Buy
13,158
+3,270
+33% +$125K 0.07% 257
2017
Q2 		$390K Sell
9,888
-285
-3% -$10.4K 0.06% 279
2017
Q1 		$319K Buy
+10,173
New +$319K 0.05% 302
2016
Q3 		– Sell
-6,723
Closed -$223K – 359
2016
Q2 		$223K Sell
6,723
-1,557
-19% -$53.3K 0.05% 316
2016
Q1 		$243K Buy
+8,280
New +$228K 0.06% 292

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Comerica Securities's EW Position: Q3 2023 in Review

Comerica Securities reduced its Edwards Lifesciences (EW) stake by 6.5% in Q3 2023, selling an estimated $27.3K and leaving 4,878 shares worth $338K. The position accounts for 0.03% of the portfolio, ranked #335.

Comerica Securities first reported a position in EW in Q1 2016 and has held it in 23 quarters since. The position peaked at $949K in Q4 2021. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Comerica Securities held 4,878 shares of Edwards Lifesciences worth $338K as of Q3 2023.
  • Comerica Securities sold 340 Edwards Lifesciences shares in Q3 2023, an estimated $27.3K.
  • Edwards Lifesciences made up 0.03% of Comerica Securities's portfolio in Q3 2023, its #335 holding.
  • Comerica Securities first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 23 quarters since.
  • Comerica Securities's Edwards Lifesciences position peaked at $949K in Q4 2021.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.